Ignite Creation Date:
2025-12-25 @ 2:22 AM
Ignite Modification Date:
2025-12-27 @ 11:53 PM
Study NCT ID:
NCT00851734
Status:
COMPLETED
Last Update Posted:
2012-06-22
First Post:
2009-02-24
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Dose-Escalation Study to Assess the Safety and Tolerability of LX214 Ophthalmic Solution in Healthy Volunteers, Followed by an Open-Label Evaluation of LX214 in Patients With Keratoconjunctivitis Sicca (KCS)
Sponsor:
Lux Biosciences, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-02
Start Date Type:
None
Primary Completion Date:
2009-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-04
Completion Date Type:
ACTUAL
First Submit Date:
2009-02-24
First Submit QC Date:
None
Study First Post Date:
2009-02-26
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2012-06-21
Last Update Post Date:
2012-06-22
Last Update Post Date Type:
ESTIMATED